The Food and Drug Administration's regulations require that new drugs be subjected to a costly testing process by the administration to determine if they are safe and effective before releasing the drugs to the public. Describe the opportunity costs of this drug testing. Could the regulations have marginal benefits that are lower than marginal costs?